Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2011 3
2012 1
2014 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean vishwanath a[au] (102 results)?
Primitive erythropoiesis in infantile haemangioma.
Itinteang T, Tan ST, Brasch HD, Vishvanath A, Day DJ. Itinteang T, et al. Among authors: vishvanath a. Br J Dermatol. 2011 May;164(5):1097-100. doi: 10.1111/j.1365-2133.2010.10187.x. Br J Dermatol. 2011. PMID: 21518328
Mesenchymal stem cells in infantile haemangioma.
Itinteang T, Vishvanath A, Day DJ, Tan ST. Itinteang T, et al. Among authors: vishvanath a. J Clin Pathol. 2011 Mar;64(3):232-6. doi: 10.1136/jcp.2010.085209. Epub 2011 Jan 17. J Clin Pathol. 2011. PMID: 21242328
Infantile haemangioma expresses embryonic stem cell markers.
Itinteang T, Tan ST, Brasch HD, Steel R, Best HA, Vishvanath A, Jia J, Day DJ. Itinteang T, et al. Among authors: vishvanath a. J Clin Pathol. 2012 May;65(5):394-8. doi: 10.1136/jclinpath-2011-200462. Epub 2012 Mar 23. J Clin Pathol. 2012. PMID: 22447921
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
Cheung L, Flemming CL, Watt F, Masada N, Yu DM, Huynh T, Conseil G, Tivnan A, Polinsky A, Gudkov AV, Munoz MA, Vishvanath A, Cooper DM, Henderson MJ, Cole SP, Fletcher JI, Haber M, Norris MD. Cheung L, et al. Among authors: vishvanath a. Biochem Pharmacol. 2014 Sep 1;91(1):97-108. doi: 10.1016/j.bcp.2014.05.023. Epub 2014 Jun 25. Biochem Pharmacol. 2014. PMID: 24973542
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
Bali P, George P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Scuto A, Annavarapu S, Fiskus W, Moscinski L, Atadja P, Bhalla K. Bali P, et al. Among authors: vishvanath a. Clin Cancer Res. 2004 Aug 1;10(15):4991-7. doi: 10.1158/1078-0432.CCR-04-0210. Clin Cancer Res. 2004. PMID: 15297399 Free article.
Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.
George P, Bali P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Fiskus W, Scuto A, Annavarapu S, Moscinski L, Bhalla K. George P, et al. Among authors: vishvanath a. Cancer Res. 2004 May 15;64(10):3645-52. doi: 10.1158/0008-5472.CAN-04-0006. Cancer Res. 2004. PMID: 15150124 Free article.